Eupraxia Pharmaceuticals Inc. Common Stock EPRX

$8.40 +12.00% at last close

Recent SEC Filings

FormDescriptionFiledDocument
6-K FORM 6-K 2026-08-13 View →
6-K 6-K 2026-08-11 View →
6-K FORM 6-K 2026-07-15 View →
6-K FORM 6-K 2026-07-13 View →
6-K FORM 6-K 2026-07-07 View →
6-K FORM 6-K 2026-06-22 View →
6-K FORM 6-K 2026-05-29 View →
6-K FORM 6-K 2026-05-29 View →
6-K FORM 6-K 2026-05-28 View →
6-K 6-K 2026-05-12 View →
6-K FORM 6-K 2026-05-06 View →
6-K FORM 6-K 2026-05-05 View →
6-K FORM 6-K 2026-05-01 View →
6-K FORM 6-K 2026-04-22 View →
6-K FORM 6-K 2026-04-21 View →
6-K FORM 6-K 2026-04-15 View →
6-K 6-K 2026-04-15 View →
6-K FORM 6-K 2026-03-17 View →
6-K 6-K 2026-03-06 View →
6-K FORM 6-K 2026-02-20 View →
6-K 6-K 2026-02-20 View →
6-K FORM 6-K 2026-02-19 View →
6-K FORM 6-K 2026-02-18 View →
6-K FORM 6-K 2026-01-08 View →
6-K FORM 6-K 2025-11-13 View →
6-K 6-K 2025-11-04 View →
6-K FORM 6-K 2025-10-01 View →
6-K 6-K 2025-09-29 View →
6-K FORM 6-K 2025-09-24 View →
6-K 6-K 2025-09-23 View →
6-K FORM 6-K 2025-09-23 View →
6-K FORM 6-K 2025-09-22 View →
6-K 6-K 2025-09-19 View →
6-K FORM 6-K 2025-09-02 View →
6-K 6-K 2025-08-13 View →
6-K FORM 6-K 2025-07-22 View →
6-K FORM 6-K 2025-07-08 View →
6-K FORM 6-K 2025-06-03 View →
6-K FORM 6-K 2025-06-02 View →
6-K FORM 6-K 2025-05-07 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$8.40
Market Cap
$555.02 million
52-Week Range
$5.04 – $9.32
Average Volume
484K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.